Skip to main content

Life

Health, medicine, wellness, beauty, nutrition, and organic living.

Life

Briefing: Momentum builds for a federal office of men’s health focused on disease prevention

Strategic angle: For advocates who have been pushing to create a federal office of men's health, this could finally be the moment.

Life

Briefing: A global food price shock looms as Middle East war rages on. Here's who will be hit hardest

Strategic angle: A widening Middle East conflict that disrupts trade through the Strait of Hormuz could ripple far beyond the energy markets, risking a spike in global food prices.

Life

Briefing: Trump touts cutting drug prices, slams fellow Republican Rep. Massie during stops in Ohio, Kentucky

Strategic angle: Trump emphasizes his commitment to lowering drug prices while criticizing Rep. Massie during campaign stops.

Life

Briefing: New view of 'frameshifting' shows how genetic info can get 'lost in translation'

Strategic angle: Christine Dunham explores the complexities of the ribosome and its role in protein synthesis.

Life

Briefing: How climate-friendly is insect protein really?

Strategic angle: Exploring the sustainability and nutritional benefits of black soldier fly larvae as a protein source.

Life

Briefing: Key Facts About Medicare Drug Price Negotiation

Strategic angle: The federal government negotiates prices for high-cost drugs under Medicare Part B and Part D.

Life

FDA Approves Leucovorin as First Drug for Rare Genetic Disorder

This approval follows previous claims of its potential use in treating autism symptoms.

Life

Briefing: How Does Health Spending in the U.S. Compare to Other Countries?

Strategic angle: This analysis examines how U.S. health spending compares to health spending in other high-income nations.

Life

Briefing: Jim Cramer on Molina Healthcare: “Lots of Exposure to Medicare and Medicaid, the Weakest Part of a Weak Business”

Strategic angle: Jim Cramer critiques Molina Healthcare's reliance on Medicare and Medicaid.

Life

Briefing: Healthcare on a lifeline: Egypt’s hospitals rely on Ramadan donations to survive

Strategic angle: In Egypt, Ramadan is not just a time for religious fasting – it is also a critical financial lifeline for the country’s public and charitable healthcare system.

Life

Briefing: Opinion: I’m a medical student. RFK Jr. is right about medical school and preventive care

Strategic angle: In medical school, a student writes, she has learned to react first, focus on prevention later.

Life

Briefing: Prison sentences for pair who attacked gay men hailed as sign of hope for Kenya’s LGBTQ+ community

Strategic angle: The sentencing of two attackers in Kenya is seen as a positive step for LGBTQ+ rights amidst rising homophobic violence.

Life

Briefing: Meissa: Multi-modal Medical Agentic Intelligence

Strategic angle: Exploring the advancements in multi-modal large language models for medical applications.

Life

Briefing: How Does Cost Affect Access to Health Care?

Strategic angle: This analysis explores trends in how the cost of healthcare affects access to care in the U.S.

Life

Briefing: Mining the dark transcriptome: Synthesizing the first potential drug molecules from long noncoding RNA

Strategic angle: A team from University of Toronto Engineering pioneers a new approach to drug discovery by synthesizing long noncoding RNA outside the cell.

Life

Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections

Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.

Life

Briefing: Soil health index finds restored mangroves can near full function

Strategic angle: Brazilian researchers have developed an index to measure mangrove soil health, showing restored areas can achieve near full functionality.

Life

Briefing: What’s next for RFK Jr.’s MAHA allies on vaccine policy?

Strategic angle: A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned.

Life

BioNTech Founders to Depart, Form New mRNA-Focused Company

Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, mRNA-focused firm.

Life

Briefing: Amid dueling autism meetings, HHS cancels

Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news